Cure Kids Ventures (CKV) is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to benefit child health. As a predominant investor in New Zealand’s seed and early stage healthcare and biotech sector, CKV has established a reputation in the investment community as an informed and value added investor. The CKV team is skilled in early stage company development and have global experience in the biotech, healthcare and medical devices industry.